Market Research Report : Stem Cell Research Market in India 2014
-
Upload
netscribes-inc -
Category
Business
-
view
956 -
download
1
description
Transcript of Market Research Report : Stem Cell Research Market in India 2014
Insert Cover Image using Slide Master View
Do not distort
Stem Cell Research Market – India
June 2014
STEM CELL RESEARCH IN INDIA 2014.PPT
SAMPLE
2
Executive Summary
Market
Drivers & Challenges
Trends
Competition
• The Stem Cell Therapy market in India was valued at INR x1 bn in 2013 which is expected to reach INR x2 bn approximately by the year 2018
• The Cord Blood Cell Banking Market was worth INR y1 bn in 2013 and is expected to reach INR y2 bn by the year 2018
• India is projected to see a rise in the number of stem cell banks and stem cell depositors in the near future
•Increasing partnerships•Increasing investments
• Efforts to increase awareness in stem cell banking• Easy financing opportunities in stem cell banking
Major Players
Stem Cell Banks Company A Company B Company C
Stem Cell Research Organizations
Organization A Organization B Organization C
Challenges• High Cost of Therapy• Capital intensive nature of research
is decelerating the market• ‘Development Costs’ of Stem Cell
therapy resulting in slow progress of the market
Drivers:• Favorable Regulatory Environment• High Patient Population• Application in Drug Development• Increasing Awareness• Growing Medical Tourism• Increasing Health related Expenditure
STEM CELL RESEARCH IN INDIA 2014.PPT 3
•Macroeconomic Indicators•Introduction•Market Overview•Drivers & Challenges•Market Value Chain•Market Trends•Potential Stem Cell Sources•Government Participation•CompetitionStem Cell BanksResearch Organizations
•Recent Developments•Strategic Recommendations•Appendix
STEM CELL RESEARCH IN INDIA 2014.PPT
Economic Indicators (1/3)
11
12
13
14
15
b2
a2
Q1
d1c1
b1
a1
Q4
c4
b4
a4
Q3
c3
b3
a3
Q2
d2c2
INR tn
2013-142012-132011-122010-11
GDP at Factor Cost: Quarterly
Inflation Rate: Monthly
-2
-1
0
1
2
q
Jul 2013 - Aug 2013
p
%
Nov 2013 - Dec 2013
t
Oct 2013 - Nov 2013
s
Sep 2013 - Oct 2013
r
Aug 2013 - Sep 2013
STEM CELL RESEARCH IN INDIA 2014.PPT
SAMPLE Research supply companies are expected to earn huge profits by producing stem cells research products
• The global stem cell research sector is expected to
grow at a rate of x1% due to a number of reasons
Liberalization of stem cell research and government
support due to the rise in the incidence of chronic diseases
are the major factors aiding growth
• USA and China have the highest volume of stem cell
research and Singapore, Italy, USA, Japan, and Israel
have the highest level of activity in this area
• Globally, there are x2 companies involved in different
areas of stem cells research and the number is
expected to grow at a rate of x3% – x4%
• Well defined guidelines for stem cell research and
therapy have been developed by the US FDA & EMEA
while the South Asian / South East Asian countries
are yet to develop guidelines in this field
Global Market – Overview Stem Cell Therapy – Market Size and Growth
t
s
r
q
p
INR bn
X%
2018e
a6
2017e
a5
2016e
a4
2015e
a3
2014e
a2
2013
a1
u
t
s
r
q
p
Nos.
Y%
2013
x2
2005
x1
Number of Stem Cell Banks Worldwide
STEM CELL RESEARCH IN INDIA 2014.PPT
Stem cell therapy market is poised to grow at a very high rate due to increasing therapeutic applications
• The Stem Cell Therapy market in India was valued atINR x1 units in 20--
• The market is expected to reach INR x6 unitsapproximately by 20--, growing at a CAGR of X% forthis time period
• The stem cell research is a key factor that propels thetherapeutic market
• Almost m stem cell transplants are carried out inIndia annually that is growing gradually
Stem Cell Therapy Market – Overview Market Size and Growth
s
r
q
p
0
INR units
X%
20--e
x6
20--e
x5
20--e
x4
20--e
x3
20--e
x2
20--
x1
20--
x0
• The Stem Cell Banking Market was worth INR y1units in 20-- and is expected to reach INR y6 units in20--
• The stem cell banking market is expected to exhibit aCAGR of Y% between 20-- and 20--
• Stem cell banking that was unheard of a few yearsback but has become popular in the recent past as aless traumatic alternative to treat neurologicaldiseases and as guarantee for the entire familyagainst several other diseases
Stem Cell Banking Market – Overview
t
s
r
q
p
0
20--
y0
INR units
Y%
20--e
y6
20--e
y5
20--e
y4
20--e
y3
20--e
y2
20--
y1
Market Size and Growth
STEM CELL RESEARCH IN INDIA 2014.PPT 7
Drivers & Challenges – Summary
Drivers
Favorable Regulatory Environment
High Patient Population
Application in Drug Development
Increasing Awareness
Growing Medical Tourism
Increasing R&D Expenditure
Challenges
High Cost of Therapy
Capital Intensive Market
High Development Cost
STEM CELL RESEARCH IN INDIA 2014.PPT
SAMPLE
8
Easy financing opportunities in stem cell banking
Increasing Partnerships
Efforts to increase awareness in stem cell
Increasing Investments
Key Trends
Trends – Summary
STEM CELL RESEARCH IN INDIA 2014.PPT
SAMPLE Porter’s Five Forces Analysis
Competitive RivalryBargaining Power of SuppliersBargaining Power of Buyers
Threat of Substitutes
Threat of New Entrants
Impactx
Impactx
Impactx
Impactx
Impactx
*Note: BEP (Break-even point)
STEM CELL RESEARCH IN INDIA 2014.PPT
SAMPLE Key Ratios of Top 3 Companies – Operational Basis (FY 2013) (1/3)
Competitive Benchmarking (2/5)
0
10
20
30
40
%
Company C
b3a3
Company B
b2a2
Company A
b1
a1
Operating Margin Net Margin
• Company A recorded operating margin of x1%, higher than that of Company B which recorded operating margin of y2% but lower than that of Company C which recorded operating margin of z3%
• Net margin for Company A , Company B and Company C are a1%, b2% and c3% respectively, wherein Company A has the highest net margin among these three companies
STEM CELL RESEARCH IN INDIA 2014.PPT
SAMPLE Public: Domestic Company – Company 1(1/5)
Key People
Products and Services
Company Information Offices and Centres – India
Corporate Address
Tel No.
Fax No.
Website
Year of Incorporation
Ticker Symbol
Stock Exchange
Name Designation
Person 1 MD and Executive Director
Person 2VC and VC of Share Transfer Committee
Person 3 Director
Person 4 Director
Head OfficeMumbai
Category Products/Services
STEM CELL RESEARCH IN INDIA 2014.PPT
SAMPLE Financial Snapshot Key Ratios
Financial Summary
• The company earned a net profit of INR x1 mn in FY 2013, as compared to net profit of INR x2 mn in FY 2012
• The company reported total income of INR y1 mn in FY 2013, registering an increase of y2% over FY 2012
• The company earned an operating margin of z1% in FY 2013, an increase of z2percentage points over FY 2012
• The company reported debt to equity ratio of a1 in FY 2013, an increase of a3% over FY 2012
Key Financial Performance Indicators
Indicators Value (20/03/2014)
Particulars y-o-y change
(2013-12)2013 2012 2011 2010
Profitability RatiosOperating Margin
Net Margin
Profit Before Tax Margin
Return on Equity
Return on Capital Employed
Return on Working Capital
Return on Assets
Return on Fixed Assets
Cost RatiosOperating costs (% of Sales)
Administration costs (% of Sales)
Interest costs (% of Sales)
Liquidity RatiosCurrent Ratio
Cash Ratio
Leverage RatiosDebt to Equity Ratio
Debt to Capital Ratio
Interest Coverage Ratio
Efficiency RatiosFixed Asset Turnover
Asset Turnover
Current Asset Turnover
Working Capital Turnover
Capital Employed Turnover
Improved Decline
Net Profit/LossTotal Income
e
d
c
b
a
s
r
q
p
2013
a4
z4
2012
a3
z3
2011
a2
z2
2010
a1
z1
Public: Domestic Company – Company 1(2/5)
STEM CELL RESEARCH IN INDIA 2014.PPT
SAMPLE Public: Domestic Company – Company 1(3/5)Key Business Segments Key Geographic Segments
A%
B%
C%
2013
b4%
2012
b3%
2011
b2%
2010
b1%
a1% C%
B%
A%
2010
y1%
x1%
2013
x4%
2012
x3%
2011
x2%
Region 2Region 1
Business Highlights
Segment 2Segment 1
Description News
Overview• The company has operations in Country A, Country B and Country C that offers treatment for acute and
chronic diseases in primary, secondary and tertiary care sectors
Services
• Specializes in 50 specialties comprising cardiac sciences, oncology, radiology and imaging, gastroenterology, neurosciences, orthopedics, critical care services and in minimally invasive surgeries and transplantation
• Operates retail pharmacy outlets all across the country
STEM CELL RESEARCH IN INDIA 2014.PPT
SAMPLE
TO
WS
Public: Domestic Company – Company 1 – SWOT Analysis (5/5)
STEM CELL RESEARCH IN INDIA 2014.PPT
SAMPLE Private: Domestic Company – Company 2(1/5)
Key People
Products and Services
Company Information Offices and Centres – India
Name Designation
Person 1 Director
Person 2 Director
Person 3 Director
Person 4 Director
Corporate Address
Tel No.
Fax No.
Website
Year of Incorporation Head Office
Category Products/Services
Ready Meals
Instant Mixes
Others
Mumbai
STEM CELL RESEARCH IN INDIA 2014.PPT
SAMPLE Private: Domestic Company – Company 2(2/5)
Shareholders of the Company Ownership Structure
Name No. of Shares held
23.6%57.4%
19.0%
Segment
Segment
Segment
STEM CELL RESEARCH IN INDIA 2014.PPT
SAMPLE
READY TO EAT MARKET IN INDIA 2014.PPT
Financial Snapshot Key Ratios
Particulars y-o-y change
(2013-12)2013 2012 2011 2010
Profitability RatiosOperating Margin
Net Margin
Profit Before Tax Margin
Return on Equity
Return on Capital Employed
Return on Working Capital
Return on Assets
Return on Fixed Assets
Cost RatiosOperating costs (% of Sales)
Administration costs (% of Sales)
Interest costs (% of Sales)
Liquidity RatiosCurrent Ratio
Cash Ratio
Leverage RatiosDebt to Equity Ratio
Debt to Capital Ratio
Interest Coverage Ratio
Efficiency RatiosFixed Asset Turnover
Asset Turnover
Current Asset Turnover
Working Capital Turnover
Capital Employed Turnover
Private: Domestic Company – Company 2(3/5)
Improved Decline
Financial Summary
• The company earned a net profit of INR x1 mn in FY 2011, as
compared to net profit of INR x2 mn in FY 2010
• The company reported total income of INR x3 mn in FY 2011,
registering an increase of x4% over FY 2010
• The company earned an operating margin of x5% in FY 2011,
an increase of x6 percentage points over FY 2010
• The company reported debt to equity ratio of x7 in FY 2011, a
decrease of x8% over FY 2010
Net Profit/LossTotal Income
a
t
s
r
q
f
p
b
c
d
e
b4
a4
20112008
a1
b1
2010
a3
b3
2009
a2
b2
STEM CELL RESEARCH IN INDIA 2014.PPT
SAMPLE
18
Description News
Overview• Company 2 has hospital network in Country A, Country B and Country C and is primarily headquartered in
Country D
• Presently located in 10 cities in India having hospitals in Region 1, Region 2 and Region 3
Facilities• Has core specialties in heart care, brain and spine, bone and joint and minimal access surgery
• Provides advanced medical diagnostics and treatment with personal care
Recognitions• Obtained NABH accreditation within one and a half years of beginning operation in India
• Hospital A, Region 1, Hospital B, Region 2 has been NABH accredited
Business Highlights
Private: Domestic Company – Company 2(3/5)
STEM CELL RESEARCH IN INDIA 2014.PPT
SAMPLE
TO
WS
Private: Domestic Company – Company 2– SWOT Analysis (5/5)
STEM CELL RESEARCH IN INDIA 2014.PPT
Thank you for the attention
About Netscribes, Inc.Netscribes, Inc. is a knowledge-consulting and solutions firm with clientele across the globe. The company’s expertise spans areas of investment & business research, business & corporate intelligence, content-management services, and knowledge-software services. At its core lies a true value proposition that draws upon a vast knowledge base. Netscribes, Inc. is a one-stop shop designed to fulfil clients’ profitability and growth objectives.
Stem Cell Research Market in India 2014– India report is part of Netscribes’ Healthcare Series.For any queries or customized research requirements, contact us at:
Disclaimer: This report is published for general information only. Although high standards have been used in the preparation, “Netscribes” is not responsible for any loss or damage arising from use of this document. This document is the sole property of Netscribes and prior permission is required for guidelines on reproduction.
Phone: +91 22 4098 7600E-Mail: [email protected]